174 related articles for article (PubMed ID: 38202341)
21. Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities.
Bashmail HA; Alamoudi AA; Noorwali A; Hegazy GA; AJabnoor G; Choudhry H; Al-Abd AM
Sci Rep; 2018 Aug; 8(1):11674. PubMed ID: 30076320
[TBL] [Abstract][Full Text] [Related]
22. Thymoquinone treatment against acetaminophen-induced hepatotoxicity in rats.
Aycan IÖ; Tüfek A; Tokgöz O; Evliyaoğlu O; Fırat U; Kavak GÖ; Turgut H; Yüksel MU
Int J Surg; 2014; 12(3):213-8. PubMed ID: 24389315
[TBL] [Abstract][Full Text] [Related]
23. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA
Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813
[TBL] [Abstract][Full Text] [Related]
24. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
[TBL] [Abstract][Full Text] [Related]
25. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
[TBL] [Abstract][Full Text] [Related]
26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
27. Thymoquinone, an active constituent of Nigella sativa seeds, binds with bilirubin and protects mice from hyperbilirubinemia and cyclophosphamide-induced hepatotoxicity.
Laskar AA; Khan MA; Rahmani AH; Fatima S; Younus H
Biochimie; 2016 Aug; 127():205-13. PubMed ID: 27265787
[TBL] [Abstract][Full Text] [Related]
28. The significance of thymoquinone administration on liver toxicity of diazinon and cholinesterase activity; a recommendation for prophylaxis among individuals at risk.
Danaei GH; Amali A; Karami M; Khorrami MB; Riahi-Zanjani B; Sadeghi M
BMC Complement Med Ther; 2022 Dec; 22(1):321. PubMed ID: 36464690
[TBL] [Abstract][Full Text] [Related]
29. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H
Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095
[TBL] [Abstract][Full Text] [Related]
30. In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1.
Kaleem M; Kayali A; Sheikh RA; Kuerban A; Hassan MA; Almalki NAR; Al-Abbasi FA; Anwar F; Omran Z; Alhosin M
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257347
[TBL] [Abstract][Full Text] [Related]
31. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa).
Ng WK; Saiful Yazan L; Yap LH; Wan Nor Hafiza WA; How CW; Abdullah R
Biomed Res Int; 2015; 2015():263131. PubMed ID: 25632388
[TBL] [Abstract][Full Text] [Related]
32. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
[TBL] [Abstract][Full Text] [Related]
33. Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice.
Ong YS; Saiful Yazan L; Ng WK; Noordin MM; Sapuan S; Foo JB; Tor YS
Int J Nanomedicine; 2016; 11():5905-5915. PubMed ID: 27877037
[TBL] [Abstract][Full Text] [Related]
34. Use of Ozone Therapy and Thymoquinone in the Prevention of Formaldehyde Toxicity by Inhalation: An Experimental Study.
Aksu F; Kavaklı A; Kuloglu T; Yilmaz S; Kaya E; Akkoc RF; Yilmaz M; Emre E; Ogetürk M
Cureus; 2024 Feb; 16(2):e54914. PubMed ID: 38544644
[TBL] [Abstract][Full Text] [Related]
35. Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro.
Khan MA; Zheng M; Fu J; Tania M; Li J; Fu J
BMC Cancer; 2022 Jun; 22(1):707. PubMed ID: 35761256
[TBL] [Abstract][Full Text] [Related]
36. Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms.
Fatfat M; Fakhoury I; Habli Z; Mismar R; Gali-Muhtasib H
Life Sci; 2019 Sep; 232():116628. PubMed ID: 31278946
[TBL] [Abstract][Full Text] [Related]
37. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties,
Shaarani S; Hamid SS; Mohd Kaus NH
Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648
[TBL] [Abstract][Full Text] [Related]
38. Thymoquinone Nanoparticles (TQ-NPs) in Kidney Toxicity Induced by Ehrlich Ascites Carcinoma (EAC): An In Vivo Study.
Eltahir Z; Ibrahim M; Mohieldeen MY; Bayoumi A; Ahmed SM
Can J Kidney Health Dis; 2024; 11():20543581241258812. PubMed ID: 38863503
[TBL] [Abstract][Full Text] [Related]
39. TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway.
Wei C; Zou H; Xiao T; Liu X; Wang Q; Cheng J; Fu S; Peng J; Xie X; Fu J
J Cell Mol Med; 2021 Nov; 25(21):10101-10110. PubMed ID: 34609056
[TBL] [Abstract][Full Text] [Related]
40. Thymoquinone enhances the antioxidant and anticancer activity of Lebanese propolis.
AlDreini S; Fatfat Z; Abou Ibrahim N; Fatfat M; Gali-Muhtasib H; Khalife H
World J Clin Oncol; 2023 May; 14(5):203-214. PubMed ID: 37275937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
